SEC 13F Intelligence

Altium Capital Management LLC / PACB

Altium Capital Management LLC’s Pacific Biosciences Calif In Position

Does Altium Capital Management LLC own Pacific Biosciences Calif In (PACB)? Not currently — the last reported position was 178.0K shares worth $2M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2023
Shares
178.0K
% of Portfolio
+1.14%
Quarters Held
2
position exited

Position History PACB

Reported value by quarter
Q4 ’22: $3MQ4 ’22Q1 ’23: $2MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2023178.0K$2M+1.14%
Q4 2022365.0K$3M+1.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of PACB.